2015 has been a good year! Sprint Bioscience signed an agreement for one of the company’s programs within tumor metabolism with Bayer HealthCare, the business expanded with several highly skilled employees, the company moves to new laboratories in Huddinge in August and another therapeutic area, type 2 diabetes, has been added to the company’s project portfolio.
We look forward to 2016 filled with new opportunities, both in science and business!
Read Redeye latest updated analysis (in Swedish) of Sprint Bioscience here.
Sprint bioscience wishes everyone a happy 2016!
Sprint Bioscience ledning: Martin Andersson, Jessica Martinsson, Anders Åberg och Anne-Marie Wenthzel
